Today: 7 February 2026
Subscribe

KLA Corporation stock jumps 6% as chip-equipment rally builds ahead of Nvidia CES keynote

KLA Corporation stock jumps 6% as chip-equipment rally builds ahead of Nvidia CES keynote

New York, Jan 5, 2026, 15:44 EST — Regular session KLA Corp (KLAC.O) shares rose about 6.4% to $1,356 in afternoon trading on Monday, after touching an intraday high of $1,371.82 and setting up for a record closing high. Morningstar The move matters because chip-equipment stocks often act as a real-time gauge of expectations for semiconductor factory spending, which can swing quickly with demand signals. The Philadelphia Semiconductor Index was up about 1% on the day, pointing to a broader bid for the sector rather than a single-stock story. Investors were also positioning ahead of the Consumer Electronics Show (CES),
5 January 2026
···
Chevron stock jumps 5% on Venezuela shake-up; what investors are watching next

Chevron stock jumps 5% on Venezuela shake-up; what investors are watching next

New York, January 5, 2026, 15:27 ET — Regular session Chevron (CVX) shares were up $8.62, or 5.5%, at $164.52 in afternoon trading, after earlier touching $171.50. The move followed weekend developments in Venezuela and U.S. comments pointing to a push for American oil companies to help rebuild the country’s oil industry, a jolt that lifted the broader energy complex. AP News Chevron is seen as the most direct U.S. beneficiary because it is the only U.S. major still operating in Venezuela under a U.S. waiver — a license that allows limited activity despite sanctions. “This type of crude aligns
5 January 2026
·
Merck stock ticks higher as MRK nears recent highs ahead of JPM Healthcare Conference

Merck stock ticks higher as MRK nears recent highs ahead of JPM Healthcare Conference

New York, January 5, 2026, 15:35 EST — Regular session Merck & Co (NYSE:MRK) shares edged up on Monday as investors looked ahead to the drugmaker’s appearance at the annual J.P. Morgan Healthcare Conference next week. The stock was up 0.3% at $106.80 at 3:35 p.m. EST, after earlier reaching $108.30. The conference is a closely watched early-year marker for healthcare stocks, often offering the first public read on management priorities before earnings season ramps up. Merck’s share performance has also been tied to investor confidence in its longer-term growth story, led by the cancer immunotherapy Keytruda and a broader
5 January 2026
··
Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

New York, Jan 5, 2026, 15:24 EST General Motors, Southwest Airlines and Tapestry ended 2025 with last-12-month buyback yields above 10% after repurchasing stock worth $8.2 billion, $2.75 billion and $2.8 billion, respectively, MarketBeat wrote on Monday. GM shares rose nearly 53% in 2025, while Southwest gained 23% and Tapestry climbed 96%, the report said. MarketBeat The renewed focus on buybacks comes as investors look for durable supports for equity returns at the start of a new year. Repurchases reduce the number of shares outstanding, which can lift earnings per share even when a company’s overall profit growth slows. That
5 January 2026
···
Uber stock slips on Melius “Sell” call as robotaxi competition looms in 2026

Uber stock slips on Melius “Sell” call as robotaxi competition looms in 2026

New York, January 5, 2026, 15:27 ET — Regular session Uber Technologies, Inc. shares were down 1.9% at $81.30 in afternoon trading on Monday, after Melius Research downgraded the ride-hailing company to “sell” with a $73 price target. “Even with Uber’s position, AV competition is set to rise in 2026 and beyond,” Melius analyst Conor Cunningham wrote, referring to autonomous vehicles, or self-driving cars. Streetinsider The call is landing at the start of a year when investors are trying to gauge how quickly robotaxis move from pilots into broader commercial service. That matters for Uber because self-driving fleets could change
5 January 2026
···
Bloom Energy stock jumps again as traders refocus on its $600 million credit line

Bloom Energy stock jumps again as traders refocus on its $600 million credit line

New York, January 5, 2026, 15:20 EST — Regular session Bloom Energy shares rose about 5.9% to $104.50 in afternoon trade on Monday as investors weighed the fuel-cell maker’s access to fresh liquidity. The stock hit an intraday high of $107.24. The move matters because financing has become a key swing factor for fast-growing clean-energy companies that still face choppy cash flows. For Bloom, balance-sheet flexibility is under scrutiny as demand builds for on-site power systems tied to data centers and other large electricity users. A revolving credit facility is essentially a bank line of credit that a company can
5 January 2026
··
Lumentum stock slides 8% as optics peers stumble; investors eye February earnings update

Lumentum stock slides 8% as optics peers stumble; investors eye February earnings update

New York, January 5, 2026, 15:24 EST — Regular session Shares of Lumentum Holdings Inc fell about 7.6% on Monday, extending a selloff across parts of the optical networking space even as the broader U.S. equity market held higher. The slide matters because Lumentum has been one of the standout winners tied to the buildout of AI data centers, leaving little room for disappointment as investors refocus on valuation and the next set of results. Lumentum closed at $386.11 on Friday, close to the 52-week high of $401.60 it hit on Dec. 24, and the stock is up about 326.9%
5 January 2026
·····
NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

New York, Jan 5, 2026, 15:21 EST — Regular session Shares of NewAmsterdam Pharma Company N.V. fell about 5% to $33.42 in afternoon trading on Monday. The Nasdaq-listed stock hit an intraday low of $32.68 after opening at $35.15. The move followed two Form 144 filings that signaled planned sales by company affiliates. In smaller biotech names, even routine insider activity can sway short-term sentiment when liquidity is thinner. Form 144 is an SEC notice filed before certain holders sell stock under Rule 144, which governs resales of restricted or “control” shares. The filing does not confirm a sale, but
5 January 2026
·
HDFC Bank share price drops after Q3 update shows loans outpacing deposits — what investors watch next

HDFC Bank share price drops after Q3 update shows loans outpacing deposits — what investors watch next

Bengaluru, Jan 6, 2026, 01:45 IST — Market closed HDFC Bank Limited’s share price fell 2.4% on Monday after its December-quarter update showed loans grew faster than deposits, putting the lender’s funding position back in focus. The stock closed at 977.5 rupees, while the Nifty 50 ended down 0.30% and the Sensex slipped 0.38% amid IT weakness and fresh U.S. tariff worries. Reuters The reaction matters now because deposit growth has lagged credit growth across India’s banking system, tightening funding and limiting how quickly lenders can expand loan books. India’s system loan-to-deposit ratio — a gauge of how much of
5 January 2026
·
Cisco stock dips as $2 billion Axonius takeover report fuels security M&A chatter

Cisco stock dips as $2 billion Axonius takeover report fuels security M&A chatter

New York, Jan 5, 2026, 15:19 EST — Regular session Cisco Systems Inc (CSCO.O) shares edged lower on Monday after an Israeli tech outlet reported the networking company is in talks to buy cybersecurity firm Axonius for about $2 billion, a deal Axonius publicly denied. ctech The report matters now because Cisco has been leaning harder into security and software to broaden growth beyond hardware, and asset visibility is a rising priority for large companies managing sprawling fleets of devices and cloud applications. A purchase would also keep attention on how Cisco deploys cash as dealmaking returns to parts of
5 January 2026
··
Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

Why Xenon Pharmaceuticals stock is down today as JPM Healthcare Conference nears

New York, January 5, 2026, 15:22 EST — Regular session Xenon Pharmaceuticals Inc (XENE) shares were down 6.5% at $41.60 in afternoon trading on Monday, about 8% off the session high. The Nasdaq-listed biotech traded between $45.21 and $41.45, with roughly 787,000 shares changing hands. The slide comes with Xenon approaching a busy stretch of investor events and trial milestones ahead of next week’s J.P. Morgan Healthcare Conference, often a tone-setter for biotech trading. Xenon’s lead molecule, azetukalner, is in Phase 3 trials — late-stage studies typically used to support drug-approval filings — in epilepsy and mood disorders, and the
5 January 2026
··
Spyre Therapeutics stock drops as biotech slides — what SYRE investors watch next

Spyre Therapeutics stock drops as biotech slides — what SYRE investors watch next

New York, January 5, 2026, 15:09 EST — Regular session Shares of Spyre Therapeutics Inc fell 2.7% to $29.75 in afternoon trading on Monday, extending a choppy start to the year for smaller biotechnology names. The stock traded between $28.02 and $30.75, with about 0.63 million shares changing hands. The decline tracked weakness across the biotech complex, with the SPDR S&P Biotech ETF down 1.7% and the iShares Nasdaq Biotechnology ETF off 1.5%. Both are exchange-traded funds, meaning baskets of stocks that trade like a single share, while the SPDR S&P 500 ETF rose 0.7%, underscoring the sector’s underperformance. That
5 January 2026
·
1 … 917 918 919 920 921 … 2,716

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
Go toTop